Published in Blood on February 15, 2002
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol (2007) 2.63
Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet (2002) 2.25
Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation (2010) 2.12
Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke (2003) 1.58
A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke. Blood (2012) 1.52
Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood (2012) 1.51
Cerebral venous thrombosis in children: a multifactorial origin. Circulation (2003) 1.46
Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study. Thromb Haemost (2008) 1.41
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation (2008) 1.26
Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood (2004) 1.24
Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion (2014) 1.20
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica (2010) 1.20
Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol (2009) 1.17
von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood (2002) 1.16
Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products. Semin Thromb Hemost (2002) 1.09
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. Blood (2013) 1.08
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol (2009) 1.08
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis. Thromb Haemost (2015) 1.06
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Blood (2013) 0.97
Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat (2007) 0.96
Anticoagulation in childhood-onset arterial ischemic stroke with non-moyamoya arteriopathy: findings from the Colorado and German (COAG) collaboration. Stroke (2009) 0.96
Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica (2010) 0.93
Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. Hum Mutat (2005) 0.93
Orthopaedic issues in sports for persons with haemophilia. Haemophilia (2007) 0.91
Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol (2011) 0.91
Health-related quality of life in children and adolescents with stroke, self-reports, and parent/proxies reports: cross-sectional investigation. Ann Neurol (2011) 0.90
Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Arterioscler Thromb Vasc Biol (2006) 0.89
Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study. Thromb Haemost (2011) 0.89
Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke. Thromb Haemost (2004) 0.89
Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration. Haematologica (2006) 0.88
Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost (2004) 0.87
Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol (2012) 0.86
Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A. Hum Mutat (2002) 0.84
Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study. J Am Soc Nephrol (2003) 0.84
Arterial ischemic stroke in neonates, infants, and children: an overview of underlying conditions, imaging methods, and treatment modalities. Semin Thromb Hemost (2003) 0.83
Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study. Ann Neurol (2012) 0.82
The factor V G1691A mutation is a risk for porencephaly: A case-control study. Ann Neurol (2004) 0.82
Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys. Haematologica (2007) 0.82
Epidemiology of inhibitors and current treatment strategies. Haematologica (2003) 0.81
Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions. Proteomics Clin Appl (2014) 0.81
Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin. Arch Dermatol (2010) 0.81
Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study. Thromb Haemost (2005) 0.81
Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients. Acta Haematol (2006) 0.81
Haemophilia A in two premature infants. Eur J Pediatr (2004) 0.80
Bleeding issues in neonates, infants and young children. Thromb Res (2009) 0.80
Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network. Blood Coagul Fibrinolysis (2015) 0.79
Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies. Semin Thromb Hemost (2011) 0.79
Interferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyser. Clin Chem Lab Med (2005) 0.78
Sense of coherence as a predictor of quality of life in adolescents with congenital heart defects: a register-based 1-year follow-up study. J Dev Behav Pediatr (2011) 0.78
Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein (a). Thromb Res (2002) 0.78
Safety and efficacy of danaparoid (Orgaran) use in children. Acta Haematol (2006) 0.77
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors. Thromb Haemost (2015) 0.77
Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat (2006) 0.77
Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol (2014) 0.77
Testing for lipoprotein(a) concentration and apolipoprotein(a) phenotypes: method standardization and pediatric reference values. Semin Thromb Hemost (2011) 0.77
Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Thromb Haemost (2014) 0.77
Thrombophilia and pregnancy complications. Thromb Haemost (2004) 0.77
Maternal thrombophilia and neonatal thrombosis. Best Pract Res Clin Haematol (2003) 0.76
Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism. Blood (2002) 0.76
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial. Thromb Haemost (2016) 0.76
Thrombophilia testing in neonates and infants with thrombosis. Semin Fetal Neonatal Med (2011) 0.76
Elevated alpha1-antitrypsin is a risk factor for arterial ischemic stroke in childhood. Acta Haematol (2006) 0.76
Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med (2002) 0.76
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population. Ann Hematol (2013) 0.76
Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study. Biomed Res Int (2013) 0.76
Acquired von Willebrand syndrome in a 10-year-old girl with acute lymphoblastic leukaemia. BMJ Case Rep (2009) 0.75
Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency. Hum Genet (2009) 0.75
EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates. Eur J Paediatr Neurol (2012) 0.75
Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost (2011) 0.75
[Contraception and thrombophilia]. Hamostaseologie (2009) 0.75
Fetal and neonatal thrombophilia. Obstet Gynecol Clin North Am (2006) 0.75
Plasma factor XIII level variations during menstrual cycle. Blood Coagul Fibrinolysis (2016) 0.75
[Thromboembolisms in childhood and adolescence]. Kinderkrankenschwester (2013) 0.75
Subcutaneous protein C concentrate in the management of severe protein C deficiency--experience from 12 centres. Br J Haematol (2014) 0.75